Cancer

Using a morphine equivalence metric to quantify opioid consumption: Examining the capacity to provide effective treatment of debilitating pain at the global, regional and country levels

Citation:

 

Gilson AM, Maurer MA, Ryan KM, Rathouz PJ, Cleary JF. Using a Morphine Equivalence Metric to Quantify Opioid Consumption: Examining the Capacity to Provide Effective Treatment of Debilitating Pain at the Global, Regional, and Country Levels. J Pain Symptom Manage 2013; 45(4):681-700.
 
Abstract:
Author: 

 

Gilson AM, Maurer MA, Ryan KM, Rathouz PJ, Cleary JF. Using a Morphine Equivalence Metric to Quantify Opioid Consumption: Examining the Capacity to Provide Effective Treatment of Debilitating Pain at the Global, Regional, and Country Levels. J Pain Symptom Manage 2013; 45(4):681-700.
 

Context

Italy reforms national policy for cancer pain relief and opioids

Citation:

Blengini C, Joranson DE, Ryan KM. Italy reforms national policy for cancer pain relief and opioids. Eur J Cancer Care 2003;12:28-34.

Abstract:
Author: 

Blengini C, Joranson DE, Ryan KM. Italy reforms national policy for cancer pain relief and opioids. Eur J Cancer Care 2003;12:28-34.

Treatment of pain caused by cancer in Italy has been reported to be inadequate for more than a decade. The problem has been documented in the literature by International Narcotics Control Board (INCB) reports that show Italy's low consumption of morphine, and by INCB statements reflecting concern that pain medications are not adequately available to suffering cancer patients. The reasons for undertreatment include lack of physician education, low public awareness about pain management and overly restrictive regulations that inhibit the prescribing of opioid analgesics.

Country: 
Syndicate content